Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
resonantmedical.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$24M

Valuation

$0000 

About Resonant Medical

Resonant Medical develops, manufactures and commercializes 3D ultrasound image-guided adaptive radiotherapy products.

Resonant Medical Headquarter Location

2050 Bleury Street, Suite 200

Montreal, Quebec, H3A 2J5,

Canada

877.985.2442 or 514.985.2442

Latest Resonant Medical News

Resonant Medical Secures Largest Medical Device Venture Capital Financing In Canada -- NULL

Aug 30, 2013

Resonant Medical Secures Largest Medical Device Venture Capital Financing In Canada MONTREAL, Dec. 15 /PRNewswire/ - Resonant Medical Inc., the technology leader in 3D ultrasound image-guided adaptive radiotherapy, announced today a $24 million Series B financing. The round was led by Ventures West and existing investor MDS Capital. Also participating were current investors BDC Venture Capital, Desjardins Venture Capital, MSBi Capital along with MMV Financial. This represents the largest venture capital investment raised by a private Canadian medical device company this year and the third largest in Canadian History. (x) "Resonant has demonstrated impressive growth and has successfully achieved important R&D, operational and commercial milestones. Resonant is now poised to deliver unique and indispensable product offerings to the radiation oncology marketplace," explains Dr. Maha Katabi, Vice-President of Ventures West. "We are now fully empowered to protect and increase our innovation and technology lead," announced Frederic Francis, CEO of Resonant Medical. "Thanks to the strong support of such top tier institutional investors, Resonant can fulfill its promises to our growing customer base and their patients. This means not only continuing to deliver the best available image-guidance for prostate cancer but also dedicating ourselves to achieving the same impact with our upcoming head & neck, breast and gynecological applications. " "We have reinvested in a first-rate organization with a solid track record and a commitment to excellence," adds Dr. Anthony Natale, Venture Partner at MDS Capital. "With this significant financial milestone, Resonant Medical is ensuring its role as the benchmark provider of image guidance for 3D conformal, intensity-modulated and adaptive radiation therapies. " Resonant's proprietary 3D ultrasound (U/S) technology allows clinicians to target tumors more accurately while safeguarding surrounding healthy tissues. Using Restitu(TM), Resonant's 3D U/S image guidance platform, radiation oncologists and medical physicists can now visualize and analyze tumor position, shape and volume during the course of patient treatment. The Restitu Platform is FDA 510k cleared and is presently being used in dozens of academic centers and cancer clinics throughout North America. The Restitu platform features significant hardware and software advances that enable physicians to achieve the level of confidence required to plan and deliver today's ever more conformal radiotherapy treatments. These features include such patent-pending technologies as Mutual Referencing(TM) which allows for ultimate patient position verification accuracy as well as Implicit Registration(TM), that permits the fusion of computed tomography (CT) and 3D U/S images for a new level of detail for radiation treatment planning. "Resonant's progress has been remarkable since our original investments," adds Dr. Lewis Slotin, seed co-investor in Resonant Medical. "Resonant now has the opportunity and resources to realize our initial vision of bringing forward breakthrough technologies that will revolutionize the way cancer patients are treated. " About Ventures West Ventures West Management Inc., a private venture capital investment group, is one of Canada's leading investors in early stage technology companies. Since its founding in 1968, Ventures West has formed eight venture capital funds representing over $700 million and has invested in more than 130 companies. Ventures West commands the expertise, capital and people needed to help entrepreneurs shape emerging technology companies into market leaders. www.ventureswest.com About MDS Capital MDS Capital Corp. and affiliates, with approximately $1 billion under management, is a leading North American venture capital company focused exclusively on providing financial support and other services to help build emerging life science companies. The company provides a continuum of capital, from early through later stages, by raising capital in public and private institutional funds. www.mdscapital.com About Desjardins Venture Capital Established in 1974, Desjardins Venture Capital is the venture capital fund management arm of the Desjardins Group. It manages the assets of Desjardins, six Desjardins regional investment funds and "Capital regional et cooperatif Desjardins", a public fund created in 2001 with authorized capitalization of $1.375-billion. www.desjardins.com/dvc About MSBi Capital MSBi Capital is a seed and early stage venture capital fund dedicated to commercializing innovations in life sciences, information technology and the physical sciences. MSBi Capital has a particular focus on establishing and building companies based on technology advancements and inventions originating from the universities of McGill, Sherbrooke and Bishop's, as well as their affiliated hospitals and research institutes. www.msbi.ca About MMV Financial MMV Financial is a Toronto-based specialty finance company providing creative debt solutions directly to mid-stage technology and life sciences companies, with a focus on the Canadian and North American sectors. MMV is backed by top U.S. and Canadian private equity firms and financial institutions including Conning Capital Partners of Hartford, Connecticut, Caisse de depot et placement du Quebec of Montreal, and Wells Fargo Foothill, a part of Wells Fargo Company. www.mmvf.com About Resonant Medical Inc. Resonant Medical Inc. is a leader in 3D ultrasound image-guided adaptive radiotherapy products which are intended to make an important contribution to the treatment of cancer through radiotherapy in the area of treatment planning, verification and delivery. The company's core product, the Restitu Platform, is designed to increase the efficacy and reduce the side effects of radiation therapy, resulting in improved quality of life for cancer patients as well as enhanced productivity of cancer centers. www.resonantmedical.com (x) Source: Thomson MacDonald SOURCE RESONANT MEDICAL INC.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Resonant Medical Patents

Resonant Medical has filed 6 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/6/2008

3/13/2012

Gastropod anatomy, Image processing, Transcription factors, Medical imaging, Mollusc shells

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/6/2008

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/13/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Gastropod anatomy, Image processing, Transcription factors, Medical imaging, Mollusc shells

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.